{{Rsnum
|rsid=3765129
|Gene=ABCC1
|Chromosome=16
|position=16056044
|Orientation=plus
|GMAF=0.1079
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCC1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 28.3 | 2.7
| HCB | 76.9 | 23.1 | 0.0
| JPT | 83.2 | 16.8 | 0.0
| YRI | 96.6 | 3.4 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 76.9 | 23.1 | 0.0
| CHD | 82.6 | 15.6 | 1.8
| GIH | 88.0 | 12.0 | 0.0
| LWK | 96.3 | 3.7 | 0.0
| MEX | 66.7 | 29.8 | 3.5
| MKK | 96.8 | 3.2 | 0.0
| TSI | 77.5 | 20.6 | 2.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3765129
|Name_s=ABCC1: IVS11 ?48C>T
|Gene_s=ABCC1
|Feature=Intron
|Evidence=PubMed ID:19940846
|Annotation=Approximately 50% of the variation in absolute neutrophil count nadir in cancer patients is explained by rs3765129, rs2306283 and UGT1a1*93.
|Drugs=
|Drug Classes=
|Diseases=Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111614
}}

{{PMID|16684361|OA=1
}} Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3765129
|overall_frequency_n=1069
|overall_frequency_d=9784
|overall_frequency=0.10926
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=5
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}